Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification. (Q53117568)
Jump to navigation
Jump to search
scientific article published in March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification. |
scientific article published in March 2013 |
Statements
Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification. (English)
Christian Morath
Changli Wei
Stephan Macher-Goeppinger
Vedat Schwenger
Martin Zeier
Jochen Reiser
1 March 2013
20
2
226-229